ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1295

Targeting Barriers That Prevent Contraception Counseling in an Academic Rheumatology Practice

Tara Skorupa1, Kristin Sturm2, Aaron Lazorwitz2, Guiset Carvajal Bedoya3, Ju Young Kwag2, JoAnn Zell2 and Kristen Demoruelle2, 1University of Colorado, Aurora, CO, 2University of Colorado Anschutz Medical Campus, Aurora, CO, 3Billings Clinic, Billings, MT

Meeting: ACR Convergence 2022

Keywords: autoimmune diseases, Women's health

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Measures and Measurement of Healthcare Quality Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Systemic autoimmune diseases disproportionately affect females of childbearing potential. Many of the medications used to treat systemic autoimmune diseases have suspected or confirmed teratogenic effects. As such, contraception counseling to prevent unplanned pregnancy is a cornerstone for optimal rheumatology clinical care. Yet, studies report inadequate rates of contraception counseling by rheumatology providers. In this study, we evaluated provider-reported barriers to contraception counseling as well as the effectiveness of several clinical interventions initiated to improve contraception counseling.

Methods: We administered an anonymous online questionnaire to outpatient rheumatology clinical providers at an academic clinical practice (N=14) asking, “What barriers do you encounter that make it difficult to talk with your female patients about contraception?”. In April 2021, we initiated six clinical interventions designed to improve feasibility and effectiveness of contraception counseling (see Table 1). A follow-up questionnaire was completed by providers 11 months after these clinical interventions. We also quantified the number of clinical referrals ordered by rheumatology providers to our affiliated Family Planning clinic, which provides contraception counseling and administers contraception for medically complicated patients.

Results: The frequency of provider-reported contraception counseling increased between pre- and post-intervention surveys, and there was an increase in provider comfort level asking patients about contraception use (Table 2). Providers reporting they were ‘comfortable’ or ‘very comfortable’ asking female patients about their contraception use increased from 79% to 100%. The intervention perceived by providers to be the most beneficial was the Check-in Form followed by the option for a Rheumatology Women’s Clinic visit (Table 1). There was a significant change in referral patterns to the Family Planning clinic. Specifically, in the two years prior to our clinical interventions (04/2019-03/2021), the total number of Family Planning clinic referrals was 9 (0.4/month), and in the 12 months after the clinical intervention (04/2021-03/2022), the number of referrals increased to 35 (2.9/month, p=0.02). Despite these interventions, barriers still exist, with the most prevalent barriers identified by providers being time constraints and patient acuity (Table 2).

Conclusion: We identified several clinical interventions that rheumatology providers found helpful to improve their comfort level when talking to female patients about contraception, particularly a quick and simple Check-In Form given to patients of childbearing potential. Our interventions increased referrals to a Family Planning clinic by a remarkable 725%. However, future studies are needed to evaluate whether the increased referral pattern resulted in increased use of effective contraception by rheumatology patients. Despite some of the positive changes we identified with our clinical interventions, barriers remain for rheumatology providers to provide effective contraception counseling to their patients.

Supporting image 1

Supporting image 2


Disclosures: T. Skorupa, None; K. Sturm, None; A. Lazorwitz, None; G. Carvajal Bedoya, None; J. Kwag, None; J. Zell, None; K. Demoruelle, Boehringer-Ingelheim, Pfizer.

To cite this abstract in AMA style:

Skorupa T, Sturm K, Lazorwitz A, Carvajal Bedoya G, Kwag J, Zell J, Demoruelle K. Targeting Barriers That Prevent Contraception Counseling in an Academic Rheumatology Practice [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/targeting-barriers-that-prevent-contraception-counseling-in-an-academic-rheumatology-practice/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/targeting-barriers-that-prevent-contraception-counseling-in-an-academic-rheumatology-practice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology